MicroRNA-146a improves sepsis-induced cardiomyopathy by regulating the TLR-4/NF-κB signaling pathway

Experimental and Therapeutic Medicine
Jin XieWenxing Fan


The aim of the current study was to investigate the regulatory effect of miR-146a on the toll-like receptor 4 (TLR-4)/NF-κB pathway and therefore inflammation in septic cardiomyopathy. A total of 60 healthy male Sprague Dawley rats were equally divided into a control, LPS, miR-146a agonist and miR-146a inhibitor group. Blood samples were collected from rats 24 h after intraperitoneal lipopolysaccharide injection and myocardial tissues were subsequently collected. After hematoxylin and eosin staining of rat myocardial tissues, the degree of inflammatory cell infiltration and myocardial damage was observed. The content of certain myocardial injury markers were also observed, including cardiac troponin I (cTnI), B-type natriuretic peptide (BNP), creatine kinase myocardial bound (CK-MB) and myoglobin (Mb). Western blot analysis was performed to detect the expression of NF-κB/TLR-4, tumor necrosis factor (TNF-α) and intercellular adhesion molecule-1 (ICAM-1) in myocardial tissues. Reverse transcription-quantitative (RT-q) PCR was used to detect the expression of miR-146a, TNF-α, interleukin (IL)-1α and IL-1β mRNA in myocardial tissues. In the LPS group, myocardial interstitial tissue edema occurred, with enlarged and loosely arrange...Continue Reading


Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Aug 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·Konstantin D TaganovDavid Baltimore
Jul 5, 2012·Current Cardiology Reviews·Francisco J Romero-BermejoMaria J Huertos-Ranchal
Nov 22, 2012·Cold Spring Harbor Perspectives in Medicine·Shira Landskroner-EigerWilliam C Sessa
Dec 5, 2012·Cardiovascular Research·Xiaohui WangChuanfu Li
Dec 18, 2013·Proteomics. Clinical Applications·Zhiyun Cao, Renã A S Robinson
Jan 15, 2014·Biochimica Et Biophysica Acta·Fei ZhouJinke Wang
Sep 19, 2014·Journal of Cellular and Molecular Medicine·Junlan FengYu Wang
Oct 5, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Roddy HiramEric Rousseau
Dec 4, 2014·Burns : Journal of the International Society for Burn Injuries·Situo ZhouXiaoyuan Huang
Jan 19, 2015·The Journal of Surgical Research·Nivin Sharawy, Christian Lehmann
Jun 7, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ming GaoChuanfu Li
Jun 19, 2015·American Journal of Physiology. Cell Physiology·Jolyane MelocheSébastien Bonnet
Aug 8, 2015·International Journal of Molecular Sciences·María Cecilia CimolaiHeiko Bugger
Sep 1, 2015·American Journal of Physiology. Lung Cellular and Molecular Physiology·Roddy HiramEric Rousseau
Sep 25, 2015·Future Medicinal Chemistry·Bianca C BernardoJulie R McMullen
Oct 17, 2015·Proceedings of the National Academy of Sciences of the United States of America·Ravi KarraKenneth D Poss
Nov 14, 2015·Journal of Intensive Care·Ryota Sato, Michitaka Nasu
Jun 28, 2016·European Journal of Pharmacology·Qin ZhouDongsheng Xiong
Oct 7, 2016·Military Medical Research·Xiuxiu Lv, Huadong Wang
Nov 11, 2016·BioMed Research International·Jinsong WeiHongsheng Lin
Jun 2, 2018·Scientific Reports·A HadarD Gurwitz
Jul 4, 2018·International Journal of Rheumatic Diseases·Sang-Cheol Bae, Young H Lee
Jul 7, 2018·Environmental Pollution·Almudena Espín-PérezTheo M C M de Kok

❮ Previous
Next ❯


Sep 11, 2020·BioMed Research International·Xiao Geng ZhuChun Feng Liu
Jan 6, 2021·International Journal of Molecular Sciences·Alice Chiara ManettiVittorio Fineschi

❮ Previous
Next ❯

Methods Mentioned


Related Concepts

Related Feeds


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.